Kowalski J - Search Results

1

Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia.

Okopien B, Cwalina L, Lebek M, Kowalski J, Zielinski M, Wisniewska-Wanat M, Kalina Z, Herman ZS. Okopien B, et al. Among authors: kowalski j. Int J Clin Pharmacol Ther. 2001 Dec;39(12):551-7. doi: 10.5414/cpp39551. Int J Clin Pharmacol Ther. 2001. PMID: 11770837 Clinical Trial.

2

Effect of simvastatin and fluvastatin on plasma fibrinogen levels in patients with primary hypercholesterolemia.

Okopień B, Krysiak R, Madej A, Belowski D, Zieliński M, Kowalski J, Herman ZS. Okopień B, et al. Among authors: kowalski j. Pol J Pharmacol. 2004 Nov-Dec;56(6):781-7. Pol J Pharmacol. 2004. PMID: 15662091 Free article. Clinical Trial.

3

Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates.

Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Herman ZS. Okopień B, et al. Among authors: kowalski j. J Cardiovasc Pharmacol. 2005 Sep;46(3):377-86. doi: 10.1097/01.fjc.0000175455.46245.c8. J Cardiovasc Pharmacol. 2005. PMID: 16116345 Clinical Trial.

4

The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia.

Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Labuzek K, Herman ZS. Okopień B, et al. Among authors: kowalski j. Atherosclerosis. 2004 Oct;176(2):327-35. doi: 10.1016/j.atherosclerosis.2004.05.009. Atherosclerosis. 2004. PMID: 15380456 Clinical Trial.

5

Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.

Madej A, Okopien B, Kowalski J, Zielinski M, Wysocki J, Szygula B, Kalina Z, Herman ZS. Madej A, et al. Among authors: kowalski j. Int J Clin Pharmacol Ther. 1998 Jun;36(6):345-9. Int J Clin Pharmacol Ther. 1998. PMID: 9660044 Clinical Trial.

6

Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb.

Kowalski J, Okopien B, Madej A, Makowiecka K, Zielinski M, Kalina Z, Herman ZS. Kowalski J, et al. Int J Clin Pharmacol Ther. 2001 Feb;39(2):48-52. doi: 10.5414/cpp39048. Int J Clin Pharmacol Ther. 2001. PMID: 11270801

7

Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.

Kowalski J, Okopień B, Madej A, Zieliński M, Belowski D, Kalina Z, Herman ZS. Kowalski J, et al. Eur J Clin Pharmacol. 2003 Jul;59(3):189-93. doi: 10.1007/s00228-003-0581-7. Epub 2003 May 17. Eur J Clin Pharmacol. 2003. PMID: 12756509 Clinical Trial.

8

Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia.

Kowalski J, Okopien B, Madej A, Zielinski M, Belowski D, Kalina Z, Herman ZS. Kowalski J, et al. Int J Clin Pharmacol Ther. 2003 Jun;41(6):241-7. doi: 10.5414/cpp41241. Int J Clin Pharmacol Ther. 2003. PMID: 12816176

9

Plasma cytokines as predictors of coronary heart disease.

Okopień B, Haberka M, Cwalina L, Kowalski J, Belowski D, Madej A, Zieliński M, Krysiak R, Labuzek K, Kalina Z, Herman ZS. Okopień B, et al. Among authors: kowalski j. Res Commun Mol Pathol Pharmacol. 2002;112(1-4):5-15. Res Commun Mol Pathol Pharmacol. 2002. PMID: 15080492 Clinical Trial.

10

The risk of atherosclerosis in patients with impaired glucose tolerance.

Okopien B, Stachura-Kulach A, Kulach A, Kowalski J, Zielinski M, Wisniewska-Wanat M, Sierant M, Kalina Z, Herman ZS. Okopien B, et al. Among authors: kowalski j. Res Commun Mol Pathol Pharmacol. 2003;113-114:87-95. Res Commun Mol Pathol Pharmacol. 2003. PMID: 15686110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,131 results

Search Page

Filters